BRPI0416979A - forma de apresentação transdérmica, lìquida ou semi-sólida, resistente a uv, com substáncia ativa fotossensìvel - Google Patents

forma de apresentação transdérmica, lìquida ou semi-sólida, resistente a uv, com substáncia ativa fotossensìvel

Info

Publication number
BRPI0416979A
BRPI0416979A BRPI0416979-4A BRPI0416979A BRPI0416979A BR PI0416979 A BRPI0416979 A BR PI0416979A BR PI0416979 A BRPI0416979 A BR PI0416979A BR PI0416979 A BRPI0416979 A BR PI0416979A
Authority
BR
Brazil
Prior art keywords
active substance
liquid
semi
transdermal
photosensitive
Prior art date
Application number
BRPI0416979-4A
Other languages
English (en)
Inventor
Hans-Peter Podhaisky
Stefan Bracht
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34486168&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0416979(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of BRPI0416979A publication Critical patent/BRPI0416979A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Inorganic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

"FORMA DE APRESENTAçãO TRANSDéRMICA, LìQUIDA OU SEMI-SóLIDA, RESISTENTE A UV, COM SUBSTáNCIA ATIVA FOTOSSENSìVEL". A invenção refere-se a formas de apresentação farmacêuticas semi-sólidas e líquidas, para uso transdérmico, com uma substância ativa farmacêutica fotossensível na faixa de UV e pelo menos um adjuvante absorvedor de luz UV (absorvedor de UV), sendo que o mesmo está presente na forma de apresentação em forma dissolvida ou dispersa. Vantajosamente, a forma de apresentação de acordo com a invenção refere-se a géis transdérmicos, cuja base de gel está composta de água, álcool, pelo menos um polímero formados de gel e, opcionalmente, outros ingredientes. Esses géis também são designados por géis hidroalcoólicos. é posta à disposição uma forma de apresentação com uma substância ativa farmacêutica fotossensível, sendo que o sistema de aplicação obtém uma alta estabilidade, sem as desvantagens conhecidas no uso das formas de aplicação transdérmicas semi-sólidas, convencionais. Nesse caso, efeitos colaterais nocivos para o usuário, possivelmente resultantes da fotoproteção visada, tal como, por exemplo, absorção de substâncias fotoprotetores pelo corpo, são mantidos os menores possíveis.
BRPI0416979-4A 2003-12-10 2004-12-06 forma de apresentação transdérmica, lìquida ou semi-sólida, resistente a uv, com substáncia ativa fotossensìvel BRPI0416979A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03028353A EP1541136A1 (de) 2003-12-10 2003-12-10 UV-Licht stabile halbfeste transdermale Systeme, die einen lichtempfindlichen Wirkstoff und einen UV-Absorber enthalten
PCT/EP2004/013839 WO2005055975A2 (de) 2003-12-10 2004-12-06 Uv-licht stabile halbfeste transdermale systeme, die einen lichtempfindlichen wirkstoff und einen uv-absorber enthalten

Publications (1)

Publication Number Publication Date
BRPI0416979A true BRPI0416979A (pt) 2007-02-21

Family

ID=34486168

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0416979-4A BRPI0416979A (pt) 2003-12-10 2004-12-06 forma de apresentação transdérmica, lìquida ou semi-sólida, resistente a uv, com substáncia ativa fotossensìvel

Country Status (24)

Country Link
EP (2) EP1541136A1 (pt)
JP (1) JP2007534643A (pt)
KR (1) KR20060096512A (pt)
CN (1) CN101415402A (pt)
AR (1) AR047140A1 (pt)
AU (1) AU2004296539B2 (pt)
BR (1) BRPI0416979A (pt)
CA (1) CA2548739C (pt)
CR (1) CR8461A (pt)
EA (1) EA010239B1 (pt)
EC (1) ECSP066689A (pt)
GT (1) GT200400261A (pt)
HN (1) HN2004000525A (pt)
IL (1) IL176208A0 (pt)
MX (1) MXPA06006534A (pt)
MY (1) MY141728A (pt)
NO (1) NO20063208L (pt)
NZ (1) NZ547733A (pt)
PE (1) PE20050863A1 (pt)
SV (1) SV2006001971A (pt)
TW (1) TW200528136A (pt)
UA (1) UA85861C2 (pt)
WO (1) WO2005055975A2 (pt)
ZA (1) ZA200605632B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI395806B (zh) 2010-04-14 2013-05-11 Ind Tech Res Inst 封裝材料
ES2617334T3 (es) 2010-09-06 2017-06-16 Bayer Intellectual Property Gmbh Parches transdérmicos de dosificación baja con liberación elevada de fármaco
WO2014152122A2 (en) * 2013-03-15 2014-09-25 Children's Medical Center Corporation Methods of altering vascular permeability and uses thereof
JP2024000555A (ja) * 2022-06-21 2024-01-09 東ソー株式会社 紫外線抑制下でのエストラジオール測定試薬の製造方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60155111A (ja) * 1983-10-20 1985-08-15 Hisamitsu Pharmaceut Co Inc 安定なケトプロフェン含有外用経皮製剤
JP2981523B2 (ja) * 1990-11-19 1999-11-22 株式会社林原生物化学研究所 皮膚外用剤
AUPN814496A0 (en) * 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
JP2001515026A (ja) * 1997-08-21 2001-09-18 ジョンソン・アンド・ジョンソン・コンシューマー・カンパニーズ・インコーポレイテッド 加齢または日光により損傷した皮膚および／または皮膚萎縮の処置のための１７−α−エストラジオールの使用
JP2000292428A (ja) * 1999-04-05 2000-10-20 Umeda Jimusho:Kk 環境化学物質の内分泌攪乱活性の新規測定方法及びその装置
JP2001129566A (ja) * 1999-11-05 2001-05-15 Mitsubishi Heavy Ind Ltd 有害物質処理方法およびその装置
FR2804024B1 (fr) * 2000-01-21 2002-09-13 Menarini France Nouvelles compositions pharmaceutiques a action anti- inflammatoire et leur procede de preparation
DE10053375C1 (de) * 2000-10-27 2002-01-24 Lohmann Therapie Syst Lts Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen
FR2834895B1 (fr) * 2002-01-22 2006-06-23 Ellipse Pharmaceuticals Compositions dermatologiques, resistantes a l'eau, avec filtres solaires, procede de fabrication et utilisations de ces compositions
ITFI20020144A1 (it) * 2002-08-01 2004-02-02 Menarini Farma Ind Formulazioni topiche stabilizzate contenenti ketoprofene.

Also Published As

Publication number Publication date
KR20060096512A (ko) 2006-09-11
PE20050863A1 (es) 2005-11-02
EP1541136A1 (de) 2005-06-15
AU2004296539B2 (en) 2008-10-09
CA2548739A1 (en) 2005-06-23
EA200601084A1 (ru) 2006-12-29
CR8461A (es) 2006-12-07
NO20063208L (no) 2006-07-10
WO2005055975A2 (de) 2005-06-23
AU2004296539A1 (en) 2005-06-23
CN101415402A (zh) 2009-04-22
MY141728A (en) 2010-06-15
CA2548739C (en) 2009-08-18
HN2004000525A (es) 2010-09-17
NZ547733A (en) 2010-02-26
WO2005055975A3 (de) 2009-03-12
EA010239B1 (ru) 2008-06-30
ECSP066689A (es) 2006-10-31
AR047140A1 (es) 2006-01-11
GT200400261A (es) 2005-10-31
EP1703892A2 (de) 2006-09-27
MXPA06006534A (es) 2006-08-01
IL176208A0 (en) 2006-10-05
JP2007534643A (ja) 2007-11-29
UA85861C2 (uk) 2009-03-10
ZA200605632B (en) 2008-06-25
SV2006001971A (es) 2006-02-15
TW200528136A (en) 2005-09-01

Similar Documents

Publication Publication Date Title
BRPI0411982A (pt) glicano de aperfeiçoamento de terapia
UY25055A1 (es) Formulaciones farmacéuticas que contienen voriconazol
BR0314943A (pt) Inibidores da proteìna reguladora da condutância transmembrana da fibrose cìstica e usos destes
AR052031A1 (es) Composicon oftalmica que comprende un componente portador acuoso y una cantidad efectiva de un componente de tonicidad, su uso para preparar un medicamento y uso de un componente portador y una cantidad efectiva de un componente polianionico para preparar dicha composicion
BR0005154A (pt) Emulsão água-em-óleo cosmética ou dermatológica, composição cosmética ou dermatológica destina á foto-proteção da pele e/ou dos cabelos, utilização de emulsão, utilização de silicone organo-modificado não-filtrante
SV2002000250A (es) Formula de dosis de droga accionada por hidrogel ref. pc10818ajtb/bb
ECSP014076A (es) Emulsiones estables para productos cosmeticos
DK519387D0 (da) Farmaceutiske praeparater indeholdende propylenglycol og/eller polyethylenglycol og urinstof som aktive hovedbestanddele samt anvendelse deraf
AR032912A1 (es) Formulacion farmaceutica
BRPI0418270A (pt) métodos de tratamento e de controle, de tratamento ou prevenção, de controle de um distúrbio do sistema nervoso central, e para reduzir ou evitar um efeito adverso, e, composição farmacêutica
AR044050A1 (es) Utilizacion de ivermectina para el tratamiento de desordenes dermatologicos
BR0111257A (pt) Formulação, e, uso de uma formulação
AR039164A1 (es) Sales de venlafaxina de baja solubilidad en agua
BRPI0015939B8 (pt) sistema terapêutico transdérmico com estabilidade aperfeiçoada e processo para a sua preparação
BR0006045A (pt) Composição que compreende uma carnitina e glutationa, útil para aumentar a absorção de glutationa e para sinergizar seus efeitos
BR0112337A (pt) Derivados de fosfolipìdeos de ácido valpróico e suas misturas
BR0014946A (pt) Uso de dipiridamol ou mopidamol na fabricação de um medicamento para o tratamento e prevenção de distúrbios da microcirculação dependentes da fibrina
BRPI0311511A8 (pt) "preparações farmacêuticas líquidas, e sua aplicação".
CO4930324A1 (es) Composicion quimica que contiene un sistema preservativo y metodo para elaborar y usar tal composicion
BR0309057A (pt) Formulações lìquidas com baixa dosagem em entecavir e uso
BR0206852A (pt) Conjugados de polìmero de neublastina e métodos para uso dos mesmos
BRPI0416979A (pt) forma de apresentação transdérmica, lìquida ou semi-sólida, resistente a uv, com substáncia ativa fotossensìvel
BR112012021532B1 (pt) Composição para tratamento de unhas com fungo
BR0008817A (pt) Composição cosmética em bastão
BRPI0416246A (pt) usos de pelo menos uma das histonas h2a, h2b, h3 ou h4, de um vetor e de anticorpos, composição farmacêutica e agente ou kit diagnóstico

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.